[1]
M. Vedamurthy and P. Humbert, “A randomized, open label, comparative, five-arm, controlled study evaluating the benefit and tolerability of oral superoxide dismutase combined with gliadin as add-on neutraceutical therapy with standard therapy in Indian patients with melasma”, Int J Res Dermatol, vol. 4, no. 4, pp. 471–478, Oct. 2018.